MedTrace Logo

PLATINUM Diversity

NCT02240810 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1501

Last updated 2019-05-15

Study results available
· View outcomes & findings →

Summary

To compile acute procedural performance and clinical outcomes data for the Promus PREMIER everolimus-eluting coronary stent system in understudied/underserved patient populations including women and minorities.

Conditions

Interventions

DEVICE

Percutaneous coronary intervention (Promus PREMIER)

Interventional coronary artery stenting with Promus PREMIER study stent.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Roxana Mehran, MD · Icahn School of Medicine at Mount Sinai

  • Wayne Batchelor, MD · Tallahassee Memorial Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-09-30
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02240810 on ClinicalTrials.gov